NHA Automatic Therapeutic Interchange Policy (Updated July 23, 2015)*

Similar documents
ADULT PATIENTS: Drug ordered Drug Supplied Exceptions. aluminum hydroxide + magnesium

PHARMA-MEDIC SERVICES INC. POLICY MANUAL

Calgary Zone LTC Formulary Autosubstitution List

Calgary Zone LTC Formulary Autosubstitution List

84:00. Skin and Mucous Membrane Agents. 84:00 Skin and Mucous Membrane Agents

ALLERGIC RHINITIS-NASAL

MARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa

Step Therapy Criteria 2019

Guide to the Modernized Reference Drug Program

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS

Calgary Long Term Care Formulary

Comparison of representative topical corticosteroid preparations (classified according to the US system)

Step Therapy Criteria (Criteria for Step Therapy-2 [ST-2] Drugs)

Medications for Type 2 Diabetes CDE Exam Preparation. Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy

MAXIMUM ALLOWABLE COST POLICY CHANGES DECEMBER 5, 2016 QUESTIONS AND ANSWERS

DT Description Price Category Price change

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %

Product List Finished Dosage Forms (FDF) B2B Business

Medications for Type 2 Diabetes CDE Exam Preparation

The Medical Letter. on Drugs and Therapeutics

Quarterly pharmacy formulary change notice

ASEBP and ARTA TARP Drugs and Reference Price by Categories

Step Therapy Requirements

Step Therapy Requirements

While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M.

Pharma X Consultancy Inc. Inventory List

FORMULARY Revised January 2019

Office of Medicaid Policy and Planning Over-the-Counter Drug Formulary ANALGESICS ANTACIDS ANTI-FLATULENTS

Calgary Long Term Care Formulary

2017 Formulary Changes Year to Date

Eucrisa. Eucrisa (crisaborole) Description

FORMULARY NOTES ABOUT FORMULARY AND PHARMACY

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 702 M %

Eucrisa. Eucrisa (crisaborole) Description

Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A for use in Northern Ireland) Sep 2015

DT Description Price Category Price change Percentage

LONG TERM CARE MEDICATIONS MANAGEMENT INITIATIVE JULY Prepared by the Long-Term Care Medications Management Working Group

ANTIDEPRESSANTS - BUPROPION

The safety and effectiveness of Dupixent in pediatric patients have not been established (1).

ADDITIONAL DRUG LISTING FOR MEDICARE & MEDI-CAL MEMBERS

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

RxBlue 2010 ST Criteria

AETNA BETTER HEALTH January 2017 Formulary Change(s)

Medication Policy Manual. Topic: Dupixent, dupilumab Date of Origin: March 10, Committee Approval: March 10, 2017 Next Review Date: May 2018

Omeprazole 10mg. Name, Restriction, Manner of administration and form OMEPRAZOLE omeprazole 10 mg enteric tablet, 30 (8332M) Max. Qty.

Annual Review of Antihypertensives - Fiscal Year 2009

Pharmacologic Treatment of Atopic Dermatitis

BULLETIN # 50. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on March 13, 2006.

High-Cost Drug Exclusions

FORMULARY Revised January 2018 NOTES ABOUT FORMULARY AND PHARMACY

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

Drug Regimen Optimization

High-Cost Drug Exclusions

TABLE OF CONTENTS (Click on a link below to view the section.)

QIPP Prescribing Comparators: Description and Specification

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

AETNA BETTER HEALTH January 2017 Formulary Change(s)

Rpts. GENERAL General Schedule (Code GE) Program Prescriber type: Dental Medical Practitioners Nurse practitioners Optometrists Midwives

Adapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017

Lisinopril 20 converting to losartan

Comparison of representative topical corticosteroid preparations (classified according to the US system)

Volume 4; Number 4 April 2010 PRESCRIBING GUIDANCE FOR HAY FEVER: SPRING / SUMMER 2010

ANTINEOPLASTIC DRUGS CHAPTER 21. Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component

ARBS MEDICATION(S) SUBJECT TO STEP THERAPY DIOVAN HCT MG TAB, DIOVAN HCT MG TABLET

$4 Prescription Program October 23, 2007

Pharmacy and Therapeutics Committee-approved Therapeutic Interchange

Amitriptyline Hydrochloride Heart Health & BP Amlodipine Besylate 5mg Norvasc Antibiotics Amoxicillin 500 mg Amoxil

See Important Reminder at the end of this policy for important regulatory and legal information.

Information in these slides is used with permission from St. Mary s Cardiac Rehab

Managing and Minimizing Flare-ups in Atopic Dermatitis

Clinical Policy: Dupilumab (Dupixent) Reference Number: ERX.SPA.49 Effective Date:

Matching, Fill in the Blank, Multiple Choice (1 point each)

Amitriptyline Hydrochloride Heart Health & BP Amlodipine Besylate 5mg Norvasc Antibiotics Amoxicillin 500 mg Amoxil

$4 Prescription Program May 5, 2008

TennCare Program TN MAC Price Change List As of: 03/30/2017

Michigan Pharmacy and Therapeutics Committee September 9, 2014 at 6:00 PM Kellogg Center, East Lansing, Michigan

Effective for all members on August 1, 2017

DRUG SCHEDULES REGULATION CHANGES JUNE 2018

National Medicines Management Programme

PRODUCT LIST GENERAL - TABLETS

Prescription benefit updates Large group

ACE Inhibitors and ARBs To Protect Your Heart? A Guide for Patients Being Treated for Stable Coronary Heart Disease

2015 Medicare Step Therapy Criteria. Last Modified: 12/31/2014 Last Submitted to CMS: 10/29/2014

Oral Agents. Fml Limits. Available Strengths NF NF

Cardiac Medications At A Glance

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply

2018 Step Therapy (ST) Criteria

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

ANGIOTENSIN RECEPTOR BLOCKERS

The Medical Letter. on Drugs and Therapeutics. Drug Some Formulations OTC/Rx Usual Dosage Comments Class Comments Cost 1

Neighborhood Medicaid Formulary Changes: June 2017

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information.

Pharmacy Providers and Prescribing Physicians. Updated Over-the-Counter Drug Formulary

TABLE OF CONTENTS (Click on a link below to view the section.)

2014 Medicare Step Therapy Criteria. Last Modified: Last Submitted to CMS:

Clinical Policy: ACEI and ARB Duplicate Therapy Reference Number: CP.PMN.61 Effective Date: Last Review Date: 05.18

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

Transcription:

NHA Automatic Therapeutic Interchange Policy (Updated July 23, 2015)* The following interchanges have been implemented to ensure rational use of select drugs, to decrease drug expenditures, and to allow interpretation of orders when the strength or dosage form is not indicated or not available. In exceptional clinical situations, the physician may override the interchange by writing "Do not substitute". This list pertains to adult patients only, unless otherwise specified. *July changes reflect addition of NH temporary Therapeutic Interchange Policies due to ongoing Drug shortages ADULT PATIENTS: Drug ordered Drug Supplied Exceptions ampicillin PO TID or QID amoxicillin (same dose) PO TID artificial eye lubricant drops Artificial tear drop with preservative; same number of drops and frequency If preservative-free drop is ordered, preservative-free will be supplied artificial eye lubricant ointment beclomethasone dipropionate INHALER 100 mcg / puff (Qvar ) benazapril bimatoprost 0.01% and 0.03% drops (Lumigan RC, Lumigan) budesonide nasal spray (Rhinocort AQ, Rhinocort Turbuhaler) caspofungin cefaclor capsule PO TID Eye lubricant ointment with preservative at same frequency If preservative-free ointment is ordered, preservative-free will be supplied fluticasone INHALER 125 mcg / puff (same number of puffs and frequency) latanoprost 0.005% drops (same number of drops and frequency) into each nostril twice daily See Table 3 micafungin 100 mg IV daily cefuroxime axetil tablet (same dose) PO BID cefazolin X mg q6h cefazolin X mg q8h NHA TIP cefazolin (same dose) plus metronidazole 500mg IV cefoxitin cetirizine PO ciclesonide cilazapril cimetidine If the ordered interval is less than or equal to Q8H (eg. Q4H or Q6H), the interval supplied will be Q8H. If the ordered interval is greater than Q8H (eg. Q12H), the ordered interval will be supplied. (eg. cefoxitin 1 g IV Q6H = cefazolin 1 g IV q8h plus metronidazole 500 mg IV Q8H) loratadine 10 mg PO daily fluticasone See Table 2 ranitidine 150 mg PO BID Exception: obstetric/gynecological infections OR Mycobacterium abscessus infections Exception: if CrCl less then 50 ml/min, an adjustment of the dose is recommended

ADULT PATIENTS: Drug ordered Drug Supplied Exceptions clotrimazole vaginal tablet/insert (any strength) clotrimazole vaginal insert 200 mg PV HS x 3 days and clotrimazole 1% cream to vaginal area PRN See Table 9 clotrimazole vaginal cream (any strength) clotrimazole vaginal cream 1%; 1 applicatorful PV HS x 6 days See Table 9 corticosteroids, topical See Table 8 desloratadine PO loratadine 10 mg PO daily enalapril maleate enalapril sodium Eprosartan Irbesartan (See chart below Table 12) erythromycin delayed release 333 mg TID Erythromycin 250 mg PO QID NHA TIP esomeprazole See Table 7 Exception: NG use or dysphagia patients etidronate and calcium (Didrocal) Acute care: TIP to cycle of calcium elemental 500 mg PO daily for 76 days then etidronate 400 mg PO daily for 14 days Exception: Didrocal Kits are restricted to residential care famotidine ranitidine 150 mg PO BID, or ranitidine 50 mg IV Q8H amlodipine felodipine See table 6 fenofibrate See Table 4 fexofenadine PO loratadine 10 mg PO daily into each nostril twice daily flunisolide nasal spray (Rhinalar) See Table 3 Temazepam (same dose) at HS flurazepam HS dosing See Table 1 fluticasone propionate (Flonase) or fluticasone furoate (Avamys) nasal spray into each nostril twice daily See Table 3 Exception: if CrCl less then 50 ml/min, an adjustment of the dose is recommended atorvastatin fluvastatin See Table 5 fosinopril framycetin dressing bactigras dressing (same frequency) Note: Stores Item ofloxacin ophthalmic drops (same number of gatifloxacin ophthalmic drops drops and frequency) Gentamicin IV/IM Tobramycin IV/IM NHA temporary therapeutic drug interchange for duration of drug shortage Exceptions: 1) gram positive synergy in serious infections (such as endocarditis) 2) neonates (while supply of preservative free gentamicin 10 mg/ml remains available) ketorolac 10 mg PO ibuprofen 400 mg PO (same frequency) lansoprazole See Table 7 Exception: pediatric patients lisinopril lovastatin atorvastatin See Table 5 Page 2 of 11

ADULT PATIENTS: Drug ordered Drug Supplied Exceptions magnesium hydroxide and mineral oil (Magnolax) milk of magnesia (same dose and frequency) Exception: Eating disorder patients Magnesium sulfate IV dose 2.5 g or less Doses greater than 2.5 g Give magnesium sulfate IV 2 g dose 5 g dose Exception: ACLS protocols, neonatal and pediatric patients, obstetrics and BCCA protocols. NHA temporary therapeutic dose interchange for duration of drug shortage Metamucil (Psyllium Powder) (for Adults) Two Psyllium wafers (stores item) at the same frequency (up to a Maximum 3 doses/24 hours) followed by a minimum of 240 ml water or other liquid (Adults) NHA TIP miconazole topical cream 2% clotrimazole topical cream 1% miconazole vaginal suppository (any strength) miconazole vaginal cream (any strength) mometasone furoate monohydrate nasal spray (Nasonex) moxifloxacin ophthalmic drops neomycin+polymixin+ hydrocortisone otic drops (Cortisporin, Cortimyxin) nifedipine XL nitrazepam HS dosing nitroglycerin sublingual tablets 0.3 mg sublingual; 0.6 mg sublingual nizatidine nystatin vaginal cream (any strength) nystatin vaginal suppository (any strength) clotrimazole vaginal insert 200 mg PV HS x 3 days and clotrimazole 1% cream to vaginal area PRN See Table 9 clotrimazole vaginal cream 1%; 1 applicatorful PV HS x 6 days See Table 9 into each nostril twice daily See Table 3 ofloxacin ophthalmic drops (same number of drops and frequency) neomycin+polymixin+dexamethasone ophthalmic drops (Maxitrol) (same number of drops and frequency) Amlodipine See Table 6 Temazepam 15 mg for each 5 mg nitrazepam See Table 1 nitroglycerin sublingual spray 0.4 mg (1 spray) sublingually; 0.8 mg (2 sprays) sublingually ranitidine 150 mg PO BID clotrimazole vaginal cream 1%; 1 applicatorful PV HS x 6 days See Table 9 clotrimazole vaginal insert 200 mg PV HS x 3 days and clotrimazole 1% cream to vaginal area PRN - See Table 9 omeprazole See Table 7 pantoprazole PO See Table 7 penicillin G 500,000 units PO penicillin V 300 mg PO (same frequency) Two Psyllium wafers (stores item) at the same frequency (up to a Maximum 3 Psyllium Powder (Metamucil) or doses/24 hours) followed by a minimum of Psyllium Granules (Prodiem) 240 ml water or other liquid (Adults) NHA TIP quinapril rabeprazole See Table 7 Exception: mometasone furoate monohydrate (Nasonex) is used for children aged 3 to 12 years Exception: obstetric indications Exception: if CrCl less then 50 ml/min, an adjustment of the dose is recommended Exception: pregnancy OR breastfeeding Page 3 of 11

ADULT PATIENTS: Drug ordered Drug Supplied Exceptions rosuvastatin atorvastatin See Table 5 Senna glycosides 8.6 mg tablet Senna glycosides 12 mg tablet NHA TIP saxagliptin linagliptin See Table 11 simvastatin atorvastatin See Table 5 sitagliptin linagliptin See Table 11 Telmisartan Irbesartan (See chart below Table 12) travoprost 0.004% drops (Travatan, latanoprost 0.005% drops (same number of Travatan-Z) drops and frequency) triamcinolone acetonide nasal into each nostril twice daily spray (Nasacort AQ) See Table 3 Temazepam 15 mg HS for each 0.125 mg triazolam triazolam HS dosing See Table 1 Valsartan Irbesartan (See chart below Table 12) Therapeutic Interchange Program Tables Table 1: Benzodiazepines for HS sedation: flurazepam 15 mg PO QHS triazolam 0.125 mg PO QHS nitrazepam 5 mg PO QHS flurazepam 30 mg PO QHS triazolam 0.25 mg PO QHS Benzodiazepines for HS sedation nitrazepam 10 mg PO QHS Other benzodiazepines available; check Formulary listing. temazepam 15 mg PO QHS temazepam 30 mg PO QHS Table 2: Inhaled Corticosteroids: Inhaled Corticosteroid Therapeutic Interchange beclomethasone dipropionate (Qvar ) 100 mcg fluticasone 125 mcg (same number of puffs and frequency) ciclesonide 200 mcg inhaled once daily fluticasone 125 mcg inhaled BID ciclesonide 400 mcg inhaled once daily fluticasone 250 mcg inhaled BID ciclesonide 400 mcg inhaled BID fluticasone 500 mcg inhaled BID Page 4 of 11

Table 3: Nasal Corticosteroids: Nasal Corticosteroid Therapeutic Interchange budesonide Nasal Spray (Rhinocort AQ,Rhinocort Turbuhaler) into each nostril twice daily flunisolide nasal solution (Rhinilar) fluticasone propionate nasal spray (Flonase) fluticasone furoate nasal spray (Avamys) mometasone furoate monohydrate nasal spray (Nasonex) triamcinolone acetonide nasal spray (Nasacort AQ) Exception: mometasone furoate monohydrate (NASONEX) is used for children aged 3 to 12 years Table 4: Fenofibrates: Fenofibrates Therapeutic Interchange fenofibrate regular release fenofibrate micronized (Lipidil Micro) fenofibrate microcoated 100 mg PO daily (Lipidil Supra) fenofibrate microcoated 160 mg PO daily (Lipidil Supra) fenofibrate nanocrystals 48 mg PO daily (Lipidil EZ) fenofibrate nanocrystals 145 mg PO daily (Lipidil EZ) As ordered As ordered fenofibrate micronized 134 mg PO daily (Lipidil Micro) fenofibrate micronized 200 mg PO daily (Lipidil Micro) fenofibrate micronized 67 mg PO daily (Lipidil Micro) fenofibrate micronized 200 mg PO daily (Lipidil Micro) Page 5 of 11

Table 5: HMG co-a Reductase Inhibitors (statins): (TOTAL DAILY DOSE) fluvastatin lovastatin rosuvastatin simvastatin atorvastatin 20 mg 10 mg - 5 mg 10 mg PO daily 40 mg 20 mg 2.5 mg 10 mg 10 mg PO daily 80 mg 40 mg 5 mg 20 mg 10 mg PO daily - 80 mg 10 mg 40 mg 20 mg PO daily - - 20 mg 80 mg 40 mg PO daily - - 40 mg - 80 mg PO daily Table 6: Calcium Channel Blockers: Calcium Channel Blockers Equivalent Doses (at same interval as original order) nifedipine XL 1 20 mg nifedipine XL 1 30 mg and 40 mg nifedipine XL 1 60 mg and 90 mg amlodipine 2.5 mg amlodipine 5 mg amlodipine 10 mg felodipine 2.5 mg felodipine 5 mg felodipine 10 mg amlodipine 2.5 mg amlodipine 5 mg amlodipine 10 mg 1 Do NOT substitute nifedipine XL in pregnancy. nifedipine XL remains on formulary for Obstetric indications Call prescriber for any doses that fall outside this interchange. (max recommended daily dose of amlodipine is 10 mg) Page 6 of 11

Table 7: Proton Pump Inhibitors (PPIs): Proton Pump Inhibitor Equivalent Doses PO orders esomeprazole 20 mg pantoprazole 20 mg PO lansoprazole 15 mg (at same interval as original order) omeprazole 10 mg rabeprazole 10 mg esomeprazole 40 mg pantoprazole 40 mg PO lansoprazole 30 mg (at same interval as original order) omeprazole 20 mg rabeprazole 20 mg NG orders* or dysphagia patients lansoprazole 15 mg esomeprazole 20 mg NG omeprazole 10 mg (at same interval as original order) pantoprazole 20 mg rabeprazole10 mg lansoprazole 30 mg or 60 mg omeprazole 20 mg or 40 mg **esomeprazole 40 mg NG DAILY pantoprazole 40 mg or 80 mg rabeprazole 20 mg or 40 mg * Exceptions: NG orders for Helicobacter pylori are exempt from this interchange and should be interchanged to esomeprazole 20 mg NG BID. ** Daily maximum esomeprazole dose for this interchange is 40 mg except for Zollinger-Ellison Syndrome Call prescriber for any doses that fall outside this interchange. Pediatric, pregnant and breastfeeding patients are exempt from this interchange. Lansoprazole or omeprazole may be used for pediatric patients. Omeprazole may be used for pregnant or breastfeeding patients. Page 7 of 11

Table 8: Topical Corticosteroids The dosage form (eg. cream, ointment, lotion) that is ordered will be dispensed. If a dosage form is not specified, the cream will be supplied. This interchange also applies to the topical corticosteroid component of a compounded combination order. If betamethasone valerate is ordered with no strength, 0.1% will be supplied. If hydrocortisone is ordered with no strength, 1% will be supplied. This interchange does not apply to mucous membrane agents (for example triamcinolone 0.1% dental paste ORACORT) POTENCY VERY POTENT betamethasone dipropionate Glycol 0.05% (Diprolene Topilene) clobetasol propionate 0.05% clobetasol propionate 0.05% (Dermovate) clobetasol propionate 0.05% halobetasol propionate 0.05% (Ultravate) clobetasol propionate 0.05% POTENT amcinonide 0.1% (Cyclocort) betamethasone valerate 0.1% betamethasone dipropionate 0.05% (Diprosone, Topisone) betamethasone valerate 0.1% desoximetasone 0.05%, 0.25% (Topicort) betamethasone valerate 0.1% fluocinonide 0.01%, 0.05% (Lidemol, Lidex, Lyderm, Topsyn) betamethasone valerate 0.1% MODERATELY POTENT betamethasone dipropionate 0.025% (Propaderm) betamethasone valerate 0.1% betamethasone valerate 0.05%, 0.1% (Betnovate) betamethasone valerate 0.1% clobetasone butyrate 0.05% (Eumovate) betamethasone valerate 0.1% diflucortolone valerate 0.1% (Nerisone) betamethasone valerate 0.1% fluocinolone acetonide 0.01%, 0.025%, (Synalar, Synamol, betamethasone valerate 0.1% Fluoderm) hydrocortisone valerate 0.2% (Westcort) betamethasone valerate 0.1% mometasone furoate 0.1% (Elocom) betamethasone valerate 0.1% prednicarbate 0.1% (Dermatop) betamethasone valerate 0.1% triamcinolone acetonide 0.05%, 0.1% (Aristocort, Kenalog, Triderm) betamethasone valerate 0.1% triamcinolone acetonide 0.5% (Aristocort C) betamethasone valerate 0.1% WEAK desonide 0.05% (Tridesilon, Desocort) hydrocortisone 1% hydrocortisone 0.5%, 1% hydrocortisone 1% hydrocortisone 1% to 2.5% (Cortate) hydrocortisone 1% hydrocortisone acetate 1% (Hyderm) hydrocortisone 1% Page 8 of 11

Table 9: Topical antifungals (vaginal): clotrimazole vaginal cream (any strength) miconazole vaginal cream (any strength) nystatin vaginal cream (any strength) Topical antifungals (vaginal) clotrimazole vaginal cream 1%; 1 applicatorful PV HS x 6 days clotrimazole vaginal tablet/insert (any strength) miconazole vaginal suppository (any strength) nystatin vaginal suppository (any strength) clotrimazole vaginal insert 200 mg PV HS x 3 days and clotrimazole 1% cream to vaginal area PRN Table 10: Angiotensin Converting Enzyme (ACE) Inhibitors: ACE Inhibitor Equivalent Doses Drug Dose* benazapril (LOTENSIN) 10 mg captopril (Capoten) No substitution cilazapril (Inhibace) 2.5 mg enalapril maleate (Vasotec) 5 mg enalapril sodium 4 mg fosinopril (Monopril) 10 mg lisinopril (Prinivil, Zestril) 10 mg perindopril (Coversyl) No substitution quinapril (Accupril) 10 mg ramipril (Altace) No substitution (Mavik) 1 mg (*The total daily dose of the original ACE inhibitor order will be used to calculate an equivalent dose for once daily administration.) Pediatric paients are exempt from this interchange. Enalapril is Restricted to pediatric patients. Page 9 of 11

Table 11: Dipeptidyl Peptidase IV (DDP-4) Inhibitors RESTRICTED to combination treatment for type 2 diabetes mellitus: a) When insulin NPH is not an option AND b) After inadequate glycemic control on maximum tolerated doses of metformin AND a sulfonylurea. THERAPEUTIC INTERCHANGE DDP-4 (or combination as ordered) Inhibitors Sitagliptin 25 mg, 50 mg, 100 mg Sitagliptin/metformin 50 mg/ 500 mg 50 mg/ 850 mg 50 mg/1000 mg Sitagliptin/metformin XR 50 mg/1000 mg Saxagliptin 2.5 mg, 5 mg Saxagliptin/metformin 2.5 mg/ 500 mg 2.5 mg / 850 mg 2.5 mg / 1000 mg Linagliptin dose (plus metformin if combination) 5 mg daily 5 mg daily with respective dose of metformin 5 mg daily with metformin 500 mg twice daily 5 mg daily 5 mg daily with respective dose of metformin. Table 12: Autosubstitution Policy for Angiotensin II Receptor Blockers (ARB s) : Angiotensin II Receptor Blocker Dose Equivalent Irbesartan Dose (Maximum 300 mg per 24 hours) Eprosartan 400 mg PO daily Irbesartan 75 mg PO daily Eprosartan 600 mg PO daily Irbesartan 150 mg PO daily Eprosartan 800 mg PO daily Irbesartan 300 mg PO daily Telmisartan 20 mg PO daily Irbesartan 75 mg PO daily Telmisartan 40 mg PO daily Irbesartan 150 mg PO daily Telmisartan 80 mg PO daily Irbesartan 300 mg PO daily Valsartan 80 mg PO daily Irbesartan 75 mg PO daily Valsartan 160 mg PO daily Irbesartan 150 mg PO daily Valsartan 320 mg PO daily Irbesartan 300 mg PO daily Page 10 of 11

This list does not apply to neonates. PEDIATRIC PATIENTS: Drug ordered Drug Supplied Exceptions anidulafungin caspofungin (any dose) desloratadine PO fexofenadine PO micafungin caspofungin 70 mg/m 2 loading dose (up to max dose of 70 mg), followed by 50 mg/m 2 IV daily (up to max dose of 50 mg) caspofungin 70 mg/m 2 loading dose (up to max dose of 70 mg), followed by 50 mg/m 2 IV daily (up to max dose of 50 mg) loratadine PO daily (dose will be based on weight/age) loratadine PO daily (dose will be based on weight/age) caspofungin 70 mg/m 2 loading dose (up to max dose of 70 mg), followed by 50 mg/m 2 IV daily (up to max dose of 50 mg) Page 11 of 11